|Bid||83.26 x 30000|
|Ask||83.66 x 30000|
|Day's range||80.64 - 80.64|
|52-week range||76.50 - 138.88|
|Beta (5Y monthly)||1.10|
|PE ratio (TTM)||51.69|
|Earnings date||12 Feb 2024 - 16 Feb 2024|
|Forward dividend & yield||0.27 (0.33%)|
|Ex-dividend date||18 Jan 2024|
|1y target est||179.17|
Revvity's (RVTY) EONIS Q System is set to transform SMA and SCID testing, advancing global healthcare for infants.
WALTHAM, Mass., November 14, 2023--Revvity, Inc. (NYSE: RVTY) will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 9:10 a.m. ET in Miami, FL.
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...